CardioTech partner wanted
This article was originally published in The Gray Sheet
Microporous polyurethane covered stent manufacturer is seeking a licensing partner to start pre-clinical trials following successful completion of an in vivo study. Study results from 11 pigs implanted with the firm's propriety ChronoFlex polyurethane stent demonstrated that the polymer "showed no signs of causing inflammation or intimal hyperplasia in the arterial walls," the Woburn, Mass. company says...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
A surprise move to unwind FDA’s efforts to end the marketing of unapproved drugs is in keeping with the overall sense of the top-down intervention in the agency’s policies at the end of the Trump Administration. It is also an unfortunate consequence of the embrace of drug pricing as part of FDA’s mission.